JP2007534702A5 - - Google Patents

Download PDF

Info

Publication number
JP2007534702A5
JP2007534702A5 JP2007509739A JP2007509739A JP2007534702A5 JP 2007534702 A5 JP2007534702 A5 JP 2007534702A5 JP 2007509739 A JP2007509739 A JP 2007509739A JP 2007509739 A JP2007509739 A JP 2007509739A JP 2007534702 A5 JP2007534702 A5 JP 2007534702A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
branched
alkoxy
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007509739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007534702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/014328 external-priority patent/WO2005112921A2/en
Publication of JP2007534702A publication Critical patent/JP2007534702A/ja
Publication of JP2007534702A5 publication Critical patent/JP2007534702A5/ja
Pending legal-status Critical Current

Links

JP2007509739A 2004-04-26 2005-04-26 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体 Pending JP2007534702A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56548904P 2004-04-26 2004-04-26
PCT/US2005/014328 WO2005112921A2 (en) 2004-04-26 2005-04-26 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity

Publications (2)

Publication Number Publication Date
JP2007534702A JP2007534702A (ja) 2007-11-29
JP2007534702A5 true JP2007534702A5 (US20080242721A1-20081002-C00053.png) 2008-06-26

Family

ID=35428831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007509739A Pending JP2007534702A (ja) 2004-04-26 2005-04-26 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体

Country Status (7)

Country Link
US (2) US7491744B2 (US20080242721A1-20081002-C00053.png)
EP (1) EP1744747A4 (US20080242721A1-20081002-C00053.png)
JP (1) JP2007534702A (US20080242721A1-20081002-C00053.png)
CN (1) CN101031289A (US20080242721A1-20081002-C00053.png)
AU (1) AU2005244770A1 (US20080242721A1-20081002-C00053.png)
CA (1) CA2562783A1 (US20080242721A1-20081002-C00053.png)
WO (1) WO2005112921A2 (US20080242721A1-20081002-C00053.png)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
WO2005002293A2 (en) * 2003-06-25 2005-01-06 Vanderbilt University Cox-2-targeted imaging agents
JP2007534702A (ja) * 2004-04-26 2007-11-29 バンダービルト・ユニバーシティ 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体
CA2593713A1 (en) * 2005-01-04 2006-07-13 Novartis Ag X-ray structure of human fpps and use for selecting fpps binding compounds
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1843734A4 (en) 2005-02-03 2008-09-10 Signum Biosciences Inc COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
EA016323B1 (ru) * 2006-01-04 2012-04-30 Саутерн Рисерч Инститьют Производные сулиндака, их применение и получение
EP2040699A4 (en) * 2006-06-19 2013-03-13 Vanderbilt University Medical Ct METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND THERAPEUTIC TARGETING OF COX-2
TW200815349A (en) * 2006-06-22 2008-04-01 Astrazeneca Ab New compounds
CN102014897B (zh) 2008-04-21 2015-08-05 西格纳姆生物科学公司 化合物、组合物和其制备方法
KR20160129109A (ko) 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-리폭시게나아제 활성화 단백질 억제제
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
WO2013059245A1 (en) * 2011-10-17 2013-04-25 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
WO2014088982A1 (en) * 2012-12-07 2014-06-12 Albert Einstein College Of Medicine Of Yeshiva University Gut barrier dysfunction treatment and prevention
CN103630519A (zh) * 2013-12-03 2014-03-12 华东理工大学 应用pH敏感的比率荧光蛋白检测酶-前药反应的方法
JP2018501261A (ja) * 2014-12-16 2018-01-18 エーディーティー ファーマシューティカルズ,エルエルシー Ras阻害インデニルアセトアミド化合物、組成物、およびその使用
US9862698B2 (en) 2014-12-16 2018-01-09 Adt Pharmaceuticals, Inc. Indenyl compounds, pharmaceutical compositions, and medical uses thereof
US20160168108A1 (en) 2014-12-16 2016-06-16 Adt Pharmaceuticals, Inc. Method of treating or preventing ras-mediated diseases
EP3773538A1 (en) * 2018-04-13 2021-02-17 Healx Limited Treatment of fragile x syndrome
JP7169008B2 (ja) 2018-04-26 2022-11-10 エーディーティー ファーマシューティカルズ,エルエルシー 抗がんインデン、インダン、アザインデン、アザインダン、医薬組成物および使用
US10329249B1 (en) 2018-10-03 2019-06-25 King Saud University Sulindac derivatives
CN110554129B (zh) * 2019-09-12 2020-09-25 浙江省农业科学院 一种特级初榨橄榄油中潜在抗炎活性成分的筛选方法
CN111402948A (zh) * 2020-04-02 2020-07-10 江苏食品药品职业技术学院 基于人工智能和动物实验数据集的药物代谢动力预测模型
US12012381B2 (en) * 2021-12-30 2024-06-18 Atai Therapeutics, Inc. Dimethyltryptamine analogues as nitric oxide delivery drugs

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196162A (en) * 1961-03-13 1965-07-20 Merck & Co Inc Indolyl aliphatic acids
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3336194A (en) * 1963-04-30 1967-08-15 Merck & Co Inc Indolyl acid amides
US3285908A (en) * 1963-04-30 1966-11-15 Merck & Co Inc Indolyl acid amides
US3470203A (en) * 1964-02-01 1969-09-30 Merck & Co Inc Intermediates for preparing 1-aroylindole-3-alkanoic acids
US3725548A (en) * 1970-05-01 1973-04-03 Merck & Co Inc Substituted indenyl acetic acids in the treatment of pain, fever or inflammation
US3654349A (en) * 1970-05-01 1972-04-04 Merck & Co Inc Substituted indenyl acetic acids
ES432545A1 (es) 1974-12-03 1976-11-16 Alter Sa Un procedimiento de preparacion de ciertos esteres metile- nicos mixtos del acido 1-(p-clorobenzoil)-5-metoxi-2-meti- indol-3-acetico.
FR2392008A1 (fr) 1977-05-02 1978-12-22 Fabre Sa Pierre Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs
DE2735537A1 (de) 1977-08-06 1979-02-22 Troponwerke Gmbh & Co Kg Indolacetoxyacetylaminosaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS5490174A (en) 1977-12-27 1979-07-17 Kanebo Ltd Novel indomethacin derivatives and their preparation
US4229447A (en) * 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
DE2926472A1 (de) 1979-06-30 1981-01-15 Thomae Gmbh Dr K Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
US4412994A (en) * 1980-04-24 1983-11-01 Interx Research Corporation Mannich-base hydroxamic acid prodrugs, compositions and use
US4381307A (en) 1980-10-31 1983-04-26 Merck & Co., Inc. Soft tertiary amine esters of bio-affecting carboxylic acids
PL131389B1 (en) 1980-11-13 1984-11-30 Krakowskie Zaklady Pharma Method of obtaining n-acyl derivatives of triptamines
JPS5872560A (ja) 1981-10-27 1983-04-30 Teikoku Chem Ind Corp Ltd インドメタシンフエニルエステル誘導体
DE3145465A1 (de) 1981-11-16 1983-05-19 Krakowskie Zakłady Farmaceutyczne "Polfa", Kraków Verfahren zur herstellung von n-acylderivaten der tryptamine
CA1187488A (en) 1982-02-02 1985-05-21 Yoichiro Ogawa Indoleacetic ester derivatives and process for preparing same
DE3206885A1 (de) 1982-02-26 1983-09-15 Troponwerke GmbH & Co KG, 5000 Köln Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS58201763A (ja) 1982-05-17 1983-11-24 Kowa Co インド−ルアセトキシ酢酸エステル
IL67445A (en) * 1982-12-09 1985-11-29 Teva Pharma Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids
JPS59161358A (ja) 1983-03-04 1984-09-12 Ss Pharmaceut Co Ltd 新規なインド−ル酢酸エステル誘導体及びその製造法
JPS60112760A (ja) 1983-11-18 1985-06-19 Green Cross Corp:The インド−ル酢酸誘導体及びその脂肪乳剤
JPS60152462A (ja) 1984-01-20 1985-08-10 Terumo Corp インド−ル酢酸アミド誘導体の製造方法
JPS60214768A (ja) 1984-04-07 1985-10-28 Fujisawa Pharmaceut Co Ltd オリゴペプチド化合物
JPS6160649A (ja) 1984-08-31 1986-03-28 Ss Pharmaceut Co Ltd 新規なエステル誘導体及びその製造法
US5016652A (en) * 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
JPS63196598A (ja) 1987-02-09 1988-08-15 Ss Pharmaceut Co Ltd 新規なプレドニゾロンエステル誘導体
JPS63275593A (ja) 1987-05-08 1988-11-14 Fujirebio Inc β−アミノエチルリン酸エステル誘導体
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
ES2058503T5 (es) 1988-03-29 1999-04-16 Univ Florida Formulaciones farmaceuticas para uso parenteral.
DE3811120A1 (de) 1988-03-31 1989-10-12 Merckle Gmbh Neopentylesterderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4943587A (en) 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5032588A (en) * 1989-12-08 1991-07-16 Abbott Laboratories Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
US5093356A (en) * 1990-01-16 1992-03-03 Merck Frosst Canada, Inc. Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US6048850A (en) * 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
US5436265A (en) * 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
WO1995004030A1 (en) 1993-08-02 1995-02-09 Commonwealth Scientific And Industrial Research Organisation Therapeutic compound - fatty acid conjugates
US5475021A (en) * 1993-12-03 1995-12-12 Vanderbilt University Compounds and compositions for inhibition of cyclooxygenase activity
ATE267798T1 (de) 1994-01-28 2004-06-15 Univ Kentucky Res Found Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
EP0746544B1 (en) 1994-02-22 1998-09-09 Merrell Pharmaceuticals Inc. Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
US5607966A (en) * 1994-12-23 1997-03-04 Alcon Laboratories, Inc. Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs
US5643943A (en) * 1994-12-23 1997-07-01 Alcon Laboratories, Inc. Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
EP0859642A2 (en) * 1995-10-17 1998-08-26 G.D. Searle & Co. Method of detecting cyclooxygenase-2
US5922742A (en) * 1996-04-23 1999-07-13 Merck Frosst Canada Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
US5965619A (en) * 1996-06-13 1999-10-12 Cell Pathways Inc. Method for treating patients having precancerous lesions with substituted indene derivatives
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US5973191A (en) * 1996-12-30 1999-10-26 Vanderbilt University Selective inhibitors of prostaglandin endoperoxide synthase-2
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
US6277878B1 (en) * 1998-09-07 2001-08-21 Pfizer Inc Substituted indole compounds as anti-inflammatory and analgesic agents
US6762182B1 (en) * 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
EP1148783B1 (en) 1999-01-07 2006-06-07 Vanderbilt University Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6306890B1 (en) * 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
EP1305285B1 (en) * 2000-07-25 2007-05-16 Merck & Co., Inc. N-substituted indoles useful in the treatment of diabetes
AU2001282410A1 (en) * 2000-08-24 2002-03-22 Dublin City University N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
AU2002211828A1 (en) * 2000-10-02 2002-04-15 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ES2376161T3 (es) 2001-01-29 2012-03-09 Janssen Pharmaceuticals, Inc. Indoles sustituidos y su utilización como antagonistas de integrinas.
US6933316B2 (en) * 2001-12-13 2005-08-23 National Health Research Institutes Indole compounds
DE10163426A1 (de) * 2001-12-21 2003-07-03 Max Planck Gesellschaft Pharmakologisch wirksame Inden-Derivate
WO2004020408A1 (en) * 2002-08-29 2004-03-11 Merck & Co., Inc. Indoles having anti-diabetic activity
WO2005002293A2 (en) 2003-06-25 2005-01-06 Vanderbilt University Cox-2-targeted imaging agents
JP2007534702A (ja) * 2004-04-26 2007-11-29 バンダービルト・ユニバーシティ 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体
EP2040699A4 (en) * 2006-06-19 2013-03-13 Vanderbilt University Medical Ct METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND THERAPEUTIC TARGETING OF COX-2

Similar Documents

Publication Publication Date Title
JP2007534702A5 (US20080242721A1-20081002-C00053.png)
JP2009529540A5 (US20080242721A1-20081002-C00053.png)
JP2008514655A5 (US20080242721A1-20081002-C00053.png)
JP2008546770A5 (US20080242721A1-20081002-C00053.png)
JP2008525416A5 (US20080242721A1-20081002-C00053.png)
JP2011527334A5 (US20080242721A1-20081002-C00053.png)
JP2005523922A5 (US20080242721A1-20081002-C00053.png)
JP2009535358A5 (US20080242721A1-20081002-C00053.png)
JP2008533191A5 (US20080242721A1-20081002-C00053.png)
JP2004516314A5 (US20080242721A1-20081002-C00053.png)
JP2007508362A5 (US20080242721A1-20081002-C00053.png)
JP2005539088A5 (US20080242721A1-20081002-C00053.png)
RU2472783C2 (ru) Аминные производные и их применение в бета-2-адренорецептор-опосредованных заболеваниях
JP2010524932A5 (US20080242721A1-20081002-C00053.png)
JP2009536221A5 (US20080242721A1-20081002-C00053.png)
JP2007508359A5 (US20080242721A1-20081002-C00053.png)
JP2010501478A5 (US20080242721A1-20081002-C00053.png)
JP2007510662A5 (US20080242721A1-20081002-C00053.png)
JP2008520662A5 (US20080242721A1-20081002-C00053.png)
JP2010511721A5 (US20080242721A1-20081002-C00053.png)
JP2011513410A5 (US20080242721A1-20081002-C00053.png)
JP2004525888A5 (US20080242721A1-20081002-C00053.png)
JP2005536519A5 (US20080242721A1-20081002-C00053.png)
JP2009504676A5 (US20080242721A1-20081002-C00053.png)
JP2007517826A5 (US20080242721A1-20081002-C00053.png)